focus -WSS

focus

author：hotspot 2025-09-29 22:54:02 - browse：23713

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： A Q&A with the global head of Boehringer Ingelheim's innovation unit

WSS

Why Charlie Gard's case is so disturbing to Americans

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Naloxone nonprofit donates 200,000 doses after FDA approval

Stroke deaths set to near 10 million globally by 2050

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

FDA panel issues narrow recommendation for Covid vaccine booster doses

explore

focus

knowledge

Continuity nursing helped my family in our darkest PICU moments

American woman, child freed after being kidnapped in Haiti last month

In age of alternative facts, a scholarly course on calling out crap

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

In age of alternative facts, a scholarly course on calling out crap

Wegovy’s successful heart trial raises vital question about weight loss

New air purifier tech could be key to improving indoor air quality

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

The high cost of giving birth even with insurance

Anavex keeps shifting the goalposts in its clinical trials

entertainment

Police still searching for prisoner who escaped from NYC hospital

Liquid biopsy for lung cancer is launched by Delfi

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Why Charlie Gard's case is so disturbing to Americans

A virus, fished out of a lake, may have saved a man’s life

What to expect at HLTH 2023, the health care industry conference

focus

entertainment

focus

focus